The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)
The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery
University Hospital, Brest
250 participants
May 15, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to demonstrate that simulation training for paramedical staff in neurosurgery departments, in announcing and accompanying patients with a brain tumor, improves patient satisfaction when a (potentially malignant) brain tumor is discovered, compared with usual care. The main question it aims to answer is: \- Are patients more satisfied (as measured by scores on the EORCT IN-PATSAT32 questionnaire) with their neurosurgical hospitalization following the discovery of a brain tumor in centers where paramedics have been trained by simulation? Researchers will compare the results of the EORTC IN-PATSAT32 questionnaire to determine whether paramedic training improves patient satisfaction between simulation-trained and untrained centers. Participants will be asked to complete the EORT IN-PATSAT32 questionnaire at the end of their hospital stay.
Eligibility
Inclusion Criteria5
- Patient over 18 years of age
- Patient covered by a social security scheme
- Patient signed informed consent form
- Patient found to have a brain tumor (potentially malignant, primary or secondary if this is the mode of entry into the disease)
- Hospitalization in the Neurosurgery Department at the time of tumor discovery, before the histological diagnosis is announced.
Exclusion Criteria2
- Patients with a personal history of cancer
- Patient without family AND unable to receive information
Interventions
Nurses and care assistants at the centers randomized to the "with training" arm will undergo a day-and-a-half of training to help them support patients diagnosed with brain tumors. Training consists of half a day of theory, followed by a day of simulation.
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06962215